E-viri
PDF
Recenzirano
Odprti dostop
-
Tremblay, Douglas; van Gerwen, Maaike; Alsen, Mathilda; Thibaud, Santiago; Kessler, Alaina; Venugopal, Sangeetha; Makki, Iman; Qin, Qian; Dharmapuri, Sirish; Jun, Tomi; Bhalla, Sheena; Berwick, Shana; Feld, Jonathan; Mascarenhas, John; Troy, Kevin; Cromwell, Caroline; Dunn, Andrew; Oh, William K.; Naymagon, Leonard
Blood, 07/2020, Letnik: 136, Številka: 1Journal Article
Tremblay and colleagues asked whether patients receiving either routine anticoagulation or antiplatelet therapy for existing conditions prior to becoming ill with COVID-19 have different outcomes from patients receiving neither therapy. After matching for existing comorbidities, this retrospective observational study finds no evidence for an effect of prediagnosis anticoagulation on mortality.
